CORZ · available-data snapshot
Core Scientific, Inc. (CORZ): Available-Data Snapshot
TickerWorth does not publish a DCF fair value for Core Scientific, Inc. (CORZ); the reason is set out below. What its filings and market data do show is below. The snapshot also sets out its trading multiples against 5 peers. Snapshot as of Oct 19, 2026.
Model by Miraaj Patel · generated from public market data · Updated Oct 19, 2026 · How these pages are made
Why is there no fair value for CORZ?
We do not publish a fair value for Core Scientific, Inc.. What we can say from its filings and market data is below.
What is CORZ's TickerWorth Score?
Scores lower than most companies we compare it with
Compared with Technology companies in US
Its strongest point: growing quickly. Its weakest: profitability is weak.
- Value · 59 of 100
Cheaper than 59% of Technology companies in US
- Price vs worth · 24 of 100
- Quality · 26 of 100
More profitable than 26% of Technology companies in US
- Financial health · 21 of 100
Financially stronger than 21% of Technology companies in US
- Growth · 92 of 100
Growing faster than 92% of Technology companies in US
- Momentum · 9 of 100
Outperformed 9% of Technology companies in US over the past year
Confidence: Medium confidence · Scored
Get the Undervalued Company of the Week.
- Price
- $14.07
- Market cap
- $4,
522, 866, 688 - 52-week high
- $30.46
- 52-week low
- $12.31
- Currency
- USD
- Exchange
- NasdaqGS
Snapshot of Oct 19, 2026, quote time not published · Prices are delayed.
What we can say
We don't publish a discounted-cash-flow fair value for Core Scientific, Inc. (CORZ) because the free data sources we rely on don't expose the multi-year financials a DCF needs — common for small or thinly-covered listings. Rather than invent numbers, this page shows an honest snapshot of what the public data does support: the current price and size, any relative valuation multiples that exist, a book-value view, and a price-based read. Treat it as a descriptive starting point, not a valuation and not investment advice.
Read the full reasoning
On the numbers we do have, CORZ trades at a recent price of $14.07, a market capitalisation of about $4,522,866,688, sitting 10% of the way up its 52-week range ($12.31–$30.46), on the NasdaqGS.
The standard alternative to a DCF is relative valuation — comparing CORZ's trading multiples against a sector benchmark. Here that gives Fwd P/E of 86.5× (richer than the peer median of 17.3×); P/S of 10.3× (cheaper than the peer median of 11.9×). A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.
Finally, a price-based read — explicitly not a valuation. CORZ is in a down-trend (price below both its 50- and 200-day averages), trading -53.8% from its 52-week high. Over the past year the stock is -28.3%. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.
CORZ vs peers
Sector benchmark (bellwethers, not direct competitors).
| Multiple | CORZ | Peer median | Read |
|---|---|---|---|
| Fwd P/E | 86.5× | 17.3× | richer than |
| P/S | 10.3× | 11.9× | cheaper than |
What does Core Scientific, Inc. do?
What does it do?
Core Scientific, Inc. provides infrastructure for high-density colocation services and digital asset mining in the United States. It operates in the Software - Infrastructure industry (Technology sector), headquartered in United States. The company employs roughly 325 people.
How does it make money?
The business turns $319M in annual revenue into profit. Out of every $100 of sales, about $7 is left as operating profit (operating margin of 6.9%), after a 32% gross margin on the products/services it sells. After all costs, taxes and interest, 0.0% of revenue becomes bottom-line net profit.
Is it financially healthy?
Financially it looks stretched: may struggle to cover its short-term bills (0.9× current ratio), and is currently lossmaking.
Who at CORZ filed insider trades?
| Date | Insider | Relationship | What happened | Value | Filing |
|---|---|---|---|---|---|
| DUCHENE TODD M | See remarks | Open-market sale | $151,160.00 | Form 4 for DUCHENE TODD M (opens sec.gov in a new tab) | |
| DUCHENE TODD M | See remarks | Open-market sale | $163,056.00 | Form 4 for DUCHENE TODD M (opens sec.gov in a new tab) | |
| Sullivan Adam Taylor | Director, Chief Executive Officer | Shares withheld (tax) | $375,657.84 | Form 4 for Sullivan Adam Taylor (opens sec.gov in a new tab) | |
| DUCHENE TODD M | See remarks | Shares withheld (tax) | $131,483.44 | Form 4 for DUCHENE TODD M (opens sec.gov in a new tab) | |
| DUCHENE TODD M | See remarks | Open-market sale | $167,586.00 | Form 4 for DUCHENE TODD M (opens sec.gov in a new tab) | |
| DUCHENE TODD M | See remarks | Open-market sale | $183,746.00 | Form 4 for DUCHENE TODD M (opens sec.gov in a new tab) |
A disclosure, not a signal to trade. Source: SEC EDGAR (Form 4). Older filings and the 90-day buying-and-selling read are part of Pro. See plans
Companies we do put a number on
Not investment advice. TickerWorth Score is a model output.
A descriptive, available-data snapshot and relative comparison — NOT a DCF, NOT a price target, and NOT investment advice. TickerWorth is not a licensed investment adviser, and these figures are estimates from public market data that can be wrong, stale or incomplete.